IT WAS RECENTLY REPORTED THAT rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR) pathway, extends the life span of mice (17) , suggesting a role for mTOR signaling in the regulation of mammalian life span. Two mTOR complexes have been identified in mammalian cells, both of which are sensitive to rapamycin inhibition ( Fig. 1) (39) . The mTOR complex-1 (mTORC1), consisting of mTOR, Raptor, mLST8, and PRAS40, is regulated by upstream TSC1/2-Rheb (14) . The TSC1/2-Rheb axis and mTORC1 integrate cellular energy levels, growth factors, and Wnt signals to regulate protein translation by phosphorylating S6 kinase 1 (S6K) and factor 4E binding protein 1 (4EBP1) (15, 44) . The mTORC2 complex, including mTOR, Rictor, Sin1, and mLST8, controls cell structure and survival by regulating protein kinase C (PKC) and Akt, but the upstream regulators of mTORC2 remain unknown (21) .
It is well known that vascular aging is accompanied by loss of smooth muscle contractility (35, 37, 41) . It is, therefore, critical to investigate how rapamycin affects smooth muscle contractility during vascular aging. Oxidative stress has been proposed to be a mediator of aging due to its important influence on a large variety of cellular processes (9, 13, 48) . H 2 O 2 production by mitochondria has been considered as a biomarker of aging (42, 43) , and increasing evidence suggests a role for H 2 O 2 production in biological aging (4, 19) . Upregulation of Nox4 has been established in the aging vasculature (30) , supporting a role for oxidative stress in the pathogenesis of vascular diseases including hypertension and atherosclerosis (2, 8, 33) .
Prolonged treatment with H 2 O 2 results in irreversible loss of the contractile response to either KCl or phenylephrine (PE) (23) , further supporting a role for oxidative stress in vascular aging. However, it is largely unknown how H 2 O 2 induces the loss of contractility. H 2 O 2 induces activation of Akt in cultured vascular smooth muscle cells (SMCs), resulting in modulation of various cell functions (34, 38) . It is possible that H 2 O 2 activates Akt to subsequently trigger the mTOR pathway, which is well known to regulate smooth muscle differentiation (12, 18, 28) .
Based on these observations, we speculated that rapamycin might reduce vascular aging through inhibition of the mTOR pathway in vascular smooth muscle activated by oxidative stress. Here we describe the inhibition by rapamycin of H 2 O 2 -induced loss of the contractile response of mouse aortic rings and mesenteric (resistance) arteries to KCl and PE. However, phosphorylation of S6K and 4EBP1, which lie downstream of mTORC1, was not increased by H 2 O 2 but rather rapamycin was found to prevent the activation of calcineurin induced by H 2 O 2 . We conclude that rapamycin inhibition of H 2 O 2 -induced dysfunction of vascular tissue is mediated by an mTORC2-calcineurin pathway, likely contributing to the life span extension induced by rapamycin in mice.
MATERIALS AND METHODS
Drugs. H2O2 (30%) was purchased from Merck. Rapamycin, actinomycin D (ActD), cycloheximide (CHX), superoxide dismutase (SOD), catalase, cyclosporine A, FK506, LY294002, Akt inhibitor IV, PE, and acetylcholine (ACh) chloride were purchased from Sigma-Aldrich.
Tissue preparation: mouse aortic and mesenteric arterial rings. C57BL/6 male mice (6-to 8-wk-old, 19 -21 g) were purchased from the Laboratory Animal Center of the Academy of Military Medical Sciences of China. All animal studies were approved by and performed according to the Guidelines for the Care and Use of Laboratory Animals in Nankai University (A5521-01), which strictly con-forms to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85-23, revised 1996). Mice were killed by decapitation, followed by removal of the thoracic aorta, which was immersed in physiological salt solution (PSS) containing the following: 114 mM NaCl, 4.7 mM KCl, 0.8 mM KH 2PO4, 1.2 mM MgCl2, 11 mM D-glucose, 25 mM NaHCO3, and 2.5 mM CaCl2, pH 7.4. After dissection, the thoracic aorta was cut into rings (ϳ2 mm in length), which were mounted horizontally in the 5-ml myograph chamber of a Multi Wire Myograph System (Danish Myo Technology, Skejbyparken, Denmark) by two metal hooks. One of the hooks was connected to a force transducer and the other to a micropositioner. In the case of endotheliumdenuded preparations, the vessels were mechanically rubbed before mounting; effective removal of the endothelium was verified by the loss of relaxation of PE-induced contractions in response to ACh (1 M). The rings were maintained in PSS that was bubbled with a 95% O 2-5% CO2 gas mixture at 37°C. Tissues were allowed to equilibrate for 60 min at a resting tension of 0.5 g. Isometric tension was recorded using Myodaq/Myodata 2.1 software (Danish Myo Technology). After equilibration, each ring was contracted with PE (1 M) followed by relaxation induced by ACh (1 M). Vessel segments displaying Ͼ50% relaxation to ACh were considered to have intact endothelium.
In addition, segments of third-order mesenteric resistance arteries (100 -180 m in diameter) were gently dissected from the surrounding adipose tissue in cold oxygenated PSS and cut into ϳ2 mm length rings, and the rings were mounted in a Wire Myograph chamber, maintained at 37°C in PSS solution, and gassed with 95% O 2-5% CO2 mixture at a resting tension of 0.5 g (4.9 mN). Two tungsten wires (25 m in diameter) were guided through the lumen of each ring segment. Tissues were allowed to equilibrate for 60 min before the experiments were carried out.
KCl (50 mM)-and PE (1 M)-induced contractile responses were measured before and after incubation for 3 h with H 2O2. Rapamycin and other inhibitors, such as cyclosporine A and FK506, were added 20 min before the application of H 2O2. After each application of contractile agonist, tissues were washed at least three times until the tension returned to baseline. The next contractile response was initiated after 45-60 min.
Western blot analysis. For Western blot analysis, tissues were collected after a 3-h incubation or after contractile responses reached ϳ95% of maximal PE-induced contraction. All tissues were collected and stored in liquid nitrogen for protein extraction. Liquid nitrogenfrozen tissues were cut into pieces and homogenized in lysis buffer (150 mM NaCl, 50 mM Tris·HCl pH 7.5, 1 mM EDTA, 1% Nonidet P-40, 0.1% SDS, 0.25% sodium deoxycholate, 1 mM PMSF, 1 mM ␤-glycerophosphate, 1 mM NaF, 1 mM Na 3VO4, and protease inhibitor cocktail tablets; Roche Molecular Biochemicals, Indianapolis, IN) and left on ice for 30 min. After centrifugation, protein concentrations were determined with the bicinchoninic acid assay (Pierce, Rockford, IL) according to the manufacturer's instructions. Equal amounts of protein from each lysate were mixed with loading buffer at 95°C for 5 min to denature the protein. Proteins were separated by SDS-PAGE and electrotransferred to polyvinylidene difluoride membranes. Nonspecific antigens were blocked by incubation at room temperature for 2 h with 5% nonfat milk in TBST (20 mM Tris·HCl pH 7.6, 136 mM NaCl, and 0.1% Tween-20). The membranes were probed for 1.5 h or overnight with the following primary antibodies: p70S6 kinase-␣, p-p70S6 kinase-␣, ␤-actin (Santa Cruz, CA), 20-kDa regulatory light chains of myosin (LC20), and p-LC20 (Cell Signaling). After five washes in TBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 1.5 h at room temperature. The membranes were washed five times in TBST, and the protein was detected by using the West Pico Chemiluminescent Substrate Kit (Pierce, Rockford, IL). Emitted light was quantified using the Molecular Image Chemidoc XRS System (Bio-Rad Laboratories), and signal intensities were normalized to ␤-actin using Quantity One software (Bio-Rad Laboratories).
Calcineurin (protein phosphatase 2B) activity measurement. Protein phosphatase 2B (PP2B) activity was measured using a commercially available kit (AK-816; BIOMOL, Plymouth Meeting, PA). The peptidyl phosphoserine phosphatase activity was measured using phosphoserine RII peptide as substrate following the time course of appearance of inorganic phosphate, detected with malachite green. Tissues were harvested in 250 l of lysis buffer (100 mM Tris pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, and 0.2% Nonidet P-40, with freshly added KI-132 protease inhibitor mixture; BIOMOL). After removal of free phosphate and nucleotides using a resin column, 5 l of tissue lysates were incubated at 30°C for 30 min with the substrate RII peptide (75 M) in 50 l of reaction buffer (100 mM Tris pH 7.5, 200 mM NaCl, 12 mM MgCl2, 1 mM DTT, 0.05% Nonidet P-40, and 1 mM CaCl2) in the absence or presence of EGTA (20 mM). Product formation was quantified by measurement of the absorbance at 630 nm following addition of 100 l of malachite green reagent. The amount of phosphate produced was calculated using a linear standard curve generated from 0 to 2 nM inorganic phosphate. PP2B activity was calculated as the difference between the amounts of phosphate produced in the absence vs. presence of EGTA.
Data analysis. Data are presented as the means Ϯ SE. The number of replicates (n) represents the number of isolated aortic ring preparations of C57BL/6 male mice. Differences were evaluated by Student's t-test (paired or unpaired) for comparison of two groups and by ANOVA for comparisons involving three or more groups. P Ͻ 0.05 was considered statistically significant. Fig. 3 . H2O2 inhibits contractile responses of mouse mesenteric arterial rings to KCl and PE. Mouse mesenteric arteries were mounted in a wire myograph for measurement of contractility and endothelium-dependent relaxation. After equilibration for 60 min, the contractile responses to KCl (left) and PE (right) were measured. Tissues were then treated with or without H2O2 (10m) for 2 h as indicated, followed by measurement of contractile responses to KCl and PE. Acetylcholine (ACh)-induced relaxations were examined after PE-induced contraction (the traces represent 4 independent experiments). D: cumulative data (rapa, rapamycin). *P Ͻ 0.05; n ϭ 4. Fig. 2A , consistent with previous studies (49, 50) . Endothelial function was assessed by the ability of ACh to induce relaxation of tissues precontracted with PE. We exam- ined the contractile responses of the tissues to membrane depolarization with KCl (50 mM) and ␣ 1 -adrenoceptor activation by PE (1 M) before and after 3-h treatment with H 2 O 2 . After 3-h incubation with vehicle, the contractile responses to KCl and PE were conserved (Fig. 2B) . However, after 3-h treatment with H 2 O 2 , aortic tissues completely lost the responses to KCl and PE (Fig. 2C) . Lower concentration of H 2 O 2 induced similar loss of contractility but required longer times of treatment (Supplemental Fig. S1 ; Supplemental Material for this article is available online at the Am J Physiol Heart Circ Physiol website). The contractile responses did not recover for up to 3 h after removal of H 2 O 2 . Catalase (Fig. 2E ), but not SOD (Fig. 2D) , prevented the loss of contraction induced by H 2 O 2 . Furthermore, catalase treatment preserved ACh-induced relaxation after 3-h treatment with H 2 O 2 (data not shown). Since resistance arteries (such as mesenteric arteries) play a more important role in blood pressure regulation than do conduit arteries (such as the aorta), we also examined the effects of H 2 O 2 on the contractile responses of mouse mesenteric arteries. H 2 O 2 (10 M) treatment resulted in complete loss of the contractile responses to KCl (50 mM) and PE (1 M) (Fig. 3) . (Fig. 4) . We verified the efficacy of both inhibitors in cultured vascular SMCs. More specifically, SMCs were cultured in the presence of 10% FBS and treated with ActD (1 M) or CHX (10 M). Thereafter, cells were pulse labeled with 5-bromo-2-deoxyuridine (BrdU) for 60 min, followed by ethanol fixation and immunostaining for incorporated BrdU as we previously described (16 (12, 27) , we pretreated the tissues with the PI3K inhibitor LY294002 and Akt inhibitor IV, followed by examination of the effect of H 2 O 2 on the contractile responses to KCl and PE. Neither LY294002 (Fig. 6C) nor Akt inhibitor IV (Fig. 6D) inhibited the H 2 O 2 -induced loss of contractility. In cultured mouse aortic SMCs, H 2 O 2 -induced activation of Akt, as indicated by an increase in p-Akt, was inhibited by pretreatment with either LY294002 or Akt inhibitor IV (Supplemental Fig.  S2 ), verifying the efficacy of the inhibitors.
Next, we measured the activity of mTOR by examining the phosphorylation of S6K in the absence or presence of H 2 O 2 with and without rapamycin pretreatment. Treatment with H 2 O 2 did not increase the level of S6K phosphorylation compared with the control (Fig. 6G) . Pretreatment with rapamycin significantly reduced the level of S6K phosphorylation in control tissues but not in H 2 O 2 -treated tissue. We conclude that the mTOR-S6K pathway is not involved in the loss of contractility induced by H 2 O 2 and the inhibitory effect of rapamycin involves another mechanism.
H 2 O 2 reduces LC 20 phosphorylation in response to PE. To further explore the mechanism underlying the effects of rapamycin, we assessed the potential regulation of phosphorylation of LC 20 following H 2 O 2 treatment in the absence and presence of rapamycin. Treatment with H 2 O 2 reduced LC 20 phosphorylation in response to PE by Ͼ90% (Fig. 7) . Most importantly, rapamycin attenuated the reduction of PE-induced LC 20 phosphorylation due to H 2 O 2 treatment, without having any effect under control conditions (Fig. 7) .
Cyclosporine A and FK506 inhibit the H 2 O 2 -induced loss of contractility of mouse aortic rings. Rapamycin is well known to interact with FKBP12, which is also a target of the calcineurin inhibitors cyclosporine A and FK506. We speculated, therefore, that cyclosporine A and FK506 may have similar inhibitory effects on the H 2 O 2 -induced loss of contractility. Cyclosporine A and FK506 partially prevented the loss of contractility induced by H 2 O 2 ( Fig. 8) , implicating FK506-binding protein FKBP12 in the H 2 O 2 -induced loss of contractility. Cyclosporine A and FK506, like rapamycin, did not preserve ACh-induced relaxation (data not shown).
Rapamycin and cyclosporine A inhibit the H 2 O 2 -induced activation of calcineurin. Finally, we quantified calcineurin activity in response to H 2 O 2 treatment in the absence and presence of rapamycin. Treatment with H 2 O 2 increased calcineurin activity, which was inhibited by rapamycin and cyclosporine A (Fig. 9) . It is notable that cyclosporine A, but not rapamycin, inhibited the basal level of calcineurin activity.
DISCUSSION
Here we report for the first time that rapamycin treatment inhibits the loss of vascular contractility induced by prolonged treatment with H 2 O 2 and provide evidence that this occurs through the mTORC2-calcineurin pathway. Given that rapamycin extends the life span of mice (17) and oxidative stress plays critical roles in aging, our findings suggest that rapamycin may reduce vascular aging by inhibiting the loss of contractility induced by oxidative stress. The same effects of H 2 O 2 and rapamycin were also observed with mouse mesenteric arteries (resistance vessels), suggesting that oxidative stress may reduce the contractile responses to various vasoactive agents and participate in the modulation of blood pressure.
It was previously proposed that H 2 O 2 -induced loss of contractility results from "nonspecific tissue damage." Although H 2 O 2 was reported to stimulate protein synthesis and gene transcription (29, 47) , we found that de novo protein synthesis and gene transcription are not involved in the loss of contractility induced by H 2 O 2 , since neither ActD nor CHX had any inhibitory effect. Rapamycin was shown to inhibit the loss of contractility, strongly suggesting the involvement of a signal transduction mechanism involving activation of mTOR in the H 2 O 2 effect. Interestingly, rapamycin did not protect endothelial cells since rapamycin treatment did not prevent the loss of ACh-induced relaxation by H 2 O 2 in either mouse aortic rings or mesenteric arteries. ACh-induced relaxation occurs through production of nitric oxide from endothelial nitric oxide synthase in endothelial cells. Therefore, it is possible that the prolonged treatment with H 2 O 2 results in damage to endothelial cells, which does not involve activation of the mTOR pathway. Since adventitia-derived H 2 O 2 was reported to impair relaxation of the rat carotid artery via SMC p38 mitogenactivated protein kinase (7), it is also possible that H 2 O 2 induces direct impairment of relaxation of mouse aortic and mesenteric smooth muscle. All these findings may, therefore, have certain implications in the pathogenesis of vascular disease involving overproduction of H 2 O 2 in vivo.
It is important to note that rapamycin is an immunosuppressant drug used to prevent rejection in organ transplantation. Rapamycin binds the cytosolic protein FKBP12 in a manner similar to FK506. However, unlike the FK506-FKBP12 complex, which inhibits the Ca 2ϩ /calmodulin-dependent protein phosphatase calcineurin (PP2B), the rapamycin-FKBP12 complex inhibits the mTOR pathway by directly binding the mTOR component of mTORC1 or mTORC2. However, it is still unknown how mTORC2 activates calcineurin in response to H 2 O 2 in mouse aortic tissues (Fig. 1) . There has been some evidence suggesting a connection between mTORC2 and calcineurin. A genome-wide two-hybrid study in Saccharomyces cerevisiae revealed that the essential homologous TORC2 effectors SLM1 and SLM2 interact with the catalytic subunit of calcineurin (46) . A functional interaction between mTORC2 and calcineurin has also been reported in a study using yeast mutants defective for TORC2, which demonstrate constitutive activation of calcineurin-dependent transcription (31) . Although the activation mechanism does not reflect the one we observed in mouse aortic tissues, it is interesting to note that the mutant of SLM1⌬C14 slm2 was hypersensitive to 5 mM H 2 O 2 treatment as shown by a growth defect (31) , suggesting that H 2 O 2 does induce a cellular response through the mTORC2 pathway.
Our findings suggest that mTORC2 is the target of rapamycin in the prolonged treatment with H 2 O 2 , since inhibitors of PI3K and Akt did not affect H 2 O 2 -induced loss of contraction and H 2 O 2 did not increase phosphorylation of S6K or 4EBP1 (Fig. 1) . It is well known that H 2 O 2 induces activation of the PI3K and Akt pathway in cultured vascular SMCs (3). It was previously reported that H 2 O 2 -induced mitogenic signaling in primary type II pneumocytes involves activation of PI3K, Akt, and mTOR, which was inhibited by rapamycin (36) . In cultured SMCs, we observed the activation of Akt by H 2 O 2 , but no increase in phosphorylation of S6K or 4EBP1 was detected (Li YN and Zheng XL, unpublished observations). Taken together, our results suggest that H 2 O 2 -induced loss of contractility is likely to occur through the mTORC2 pathway. Although FKBP12-rapamycin-associated protein is reported to associate with mitochondria and senses osmotic stress via mitochondrial dysfunction (11), it remains unknown how H 2 O 2 activates mTORC2 to activate calcineurin (Fig. 1) . Because mTORC2 has an important function in phosphorylation of both the turn motif and the hydrophobic motif in all conventional PKCs, novel PKCε, and Akt ( Fig. 1) (40) , and the mTORC2-dependent turn motif phosphorylation is essential for PKC␣ maturation, stability, and signaling (22) , we speculate that PKC may also be involved in the rapamycin effect on H 2 O 2 -induced loss of contractility.
Like rapamycin, the calcineurin inhibitors cyclosporine A and FK506, two structurally dissimilar immunosuppressive drugs (45) , inhibited the loss of contractility of mouse aortic rings, strongly suggesting that H 2 O 2 -induced loss of contractility is through activation of calcineurin. This was confirmed by our finding that H 2 O 2 stimulates calcineurin in a rapamycinsensitive manner. The inhibition of H 2 O 2 -induced activation of calcineurin by rapamycin further supports cross talk between mTORC2 and calcineurin. It is known that calcineurin stimulates calcium-activated chloride channels [I CI(Ca) ] by dephosphorylation of the channel, which results in membrane hyperpolarization and reduction of Ca 2ϩ influx through voltagedependent Ca 2ϩ channels (25, 26) . Therefore, it is possible that H 2 O 2 -induced activation of I CI(Ca) antagonizes PE-induced LC 20 phosphorylation via a decrease in cytosolic free Ca 2ϩ concentration (Fig. 1) .
Note that FK506 and rapamycin disrupt the association between FKBP12 and the inositol 1,4,5-trisphosphate receptor (IP3R) and displace the accessory proteins from the channel (5, 6, 10) . IP3Rs are critically involved in the contraction of smooth muscle by increasing the cytoplasmic Ca 2ϩ concentration via release from the sarcoplasmic reticulum. Therefore, it is likely that prolonged treatment with H 2 O 2 results in depletion of intracellular Ca 2ϩ stores and/or inactivation of IP3Rs, which can be interrupted by rapamycin through an undefined mechanism. This speculation is supported by our finding that prolonged treatment with H 2 O 2 reduces the phosphorylation of LC 20 , which is inhibited by pretreatment with rapamycin.
Finally, rapamycin is known to inhibit the proliferation and migration of vascular SMCs and also reduces vascular neointimal formation in different animal models. Clinical use of rapamycin-eluting stents promotes significant reductions in in-stent restenosis rates. It is important to note that in vitro incubation with high concentrations of rapamycin did not modify either contraction or relaxation of rat aortic rings (32) . Oral administration of rapamycin did not change the tone of rat aortic rings in vitro (32) . These findings, which have been confirmed in our laboratory (Gao K and Zheng XL, unpublished observations), strongly suggest that rapamycin does not change the basal levels of contractility of vascular smooth muscle tissues.
Taken together, our results reveal that rapamycin inhibits the loss of contractility induced by H 2 O 2 , suggesting that rapamycin inhibition of oxidative stress-induced vascular dysfunction may contribute to its effect on aging. We provide evidence that the mechanism underlying this rapamycin effect involves the mTORC2-calcineurin pathway, which has potential implications to our understanding of regulation of vascular contractility by oxidative stress.
